Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Clinical Rheumatology|April 15, 2018
Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trialVioletta Opoka-Winiarska, Zbigniew Żuber, Ekaterina Alexeeva, et al.
Rheumatology International|April 12, 2018
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Irina Nikishina, Ekaterina Alexeeva, Svetlana Arsenyeva, et al.
Vaccines|February 26, 2025
The Efficacy and Safety of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and <i>Haemophilus influenzae</i> Type b Infections in Children with Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort StudyEkaterina Alexeeva, Tatyana Dvoryakovskaya, Anna Fetisova, et al.
Vaccines|June 27, 2025
Safety and Efficacy of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus Type B Infections in Children with Systemic Juvenile Idiopathic Arthritis: Prospective Cohort StudyEkaterina Alexeeva, Tatyana Dvoryakovskaya, Dmitry Kudlay, et al.
Modern Rheumatology|August 29, 2018
Comparative analysis of the etanercept efficacy in children with juvenile idiopathic arthritis under the age of 4 years and children of older age groups using the propensity score matching methodEkaterina Alexeeva, Tatyana Dvoryakovskaya, Rina Denisova, et al.
Pediatrics and Neonatology|March 20, 2019
Dynamics of concomitant therapy in children with juvenile idiopathic arthritis treated with etanercept and methotrexateEkaterina Alexeeva, Tatyana Dvoryakovskaya, Rina Denisova, et al.
Pediatric Rheumatology Online Journal|January 7, 2021
Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trialEkaterina Alexeeva, Gerd Horneff, Tatyana Dvoryakovskaya, et al.
Frontiers in Pediatrics|March 13, 2023
Efficacy and safety of canakinumab as a second line biologic after tocilizumab treatment failure in children with systemic juvenile idiopathic arthritis: A single-centre cohort study using routinely collected health dataEkaterina Alexeeva, Elizaveta Krekhova, Tatyana Dvoryakovskaya, et al.
Pediatric Rheumatology Online Journal|November 19, 2022
Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis: results from the international Pharmachild registryJoeri W van Straalen, Sytze de Roock, Gabriella Giancane, et al.
RMD Open|March 8, 2022
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritisAlessandra Alongi, Gabriella Giancane, Roberta Naddei, et al.
Pageof 4